A Study of Multiple Doses of Lasmiditan in Healthy Participants

NCT03252015 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Probe Drug Cocktail
DRUG: Lasmiditan
DRUG: Placebo

Sponsor

Eli Lilly and Company